Mechanisms of toxicity associated with six tyrosine kinase inhibitors in human hepatocyte cell lines
Author:
Affiliation:
1. Division of Clinical Pharmacology & Toxicology; University Hospital; Basel Switzerland
2. Department of Biomedicine; University of Basel; Switzerland
3. Swiss Centre of Applied Human Toxicology; Switzerland
Funder
Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
Publisher
Wiley
Subject
Toxicology
Reference61 articles.
1. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma;Abou-Alfa;Journal of Clinical Oncology,2006
2. Acute liver failure due to regorafenib may be caused by impaired liver blood flow: A case report;Akamine;Anticancer Research,2015
3. Mitochondria, oxidants, and aging;Balaban;Cell,2005
4. Comparison of liver cell models using the Basel phenotyping cocktail;Berger;Frontiers in Pharmacology,2016
5. A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H;Bible;Journal of Clinical Endocrinology and Metabolism,2014
Cited by 51 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Investigation of the role of NLRP3 inflammasome activation in new-generation BCR-ABL1 tyrosine kinase inhibitors-induced hepatotoxicity;Toxicology Letters;2024-10
2. Underlying mechanisms and management strategies for regorafenib-induced toxicity in hepatocellular carcinoma;Expert Opinion on Drug Metabolism & Toxicology;2024-09-03
3. Empagliflozin mitigates ponatinib-induced cardiotoxicity by restoring the connexin 43-autophagy pathway;Biomedicine & Pharmacotherapy;2024-09
4. Non-Small-Cell Lung Cancers (NSCLCs) Harboring RET Gene Fusion, from Their Discovery to the Advent of New Selective Potent RET Inhibitors: “Shadows and Fogs”;Cancers;2024-08-19
5. Hepatotoxicity of epidermal growth factor receptor - tyrosine kinase inhibitors (EGFR-TKIs);Drug Metabolism Reviews;2024-08-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3